TOYODA MASAO

Փ��

Cost-effective analysis focused on hypoglycemia of intermittent-scanning continuous glucose monitoring in type 1 diabetes adults: a ISCHIA randomized clinical trial

Comparison of Points in Range Measured by the Self-monitoring of Blood Glucose and Time in Range Measured by the Continuous Glucose Monitoring.

Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium�\glucose cotransporter�\2 inhibitor and glucagon�\like peptide�\1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease

Influence of the combination of SGLT2 inhibitors and GLP-1 receptor agonists on eGFR decline in type 2 diabetes: post-hoc analysis of RECAP study

Predictors of the effectiveness of isCGM usage in adults with type 1 diabetes mellitus: post-hoc analysis of the ISCHIA study

Difference in the accuracy of the third-generation algorithm and the first-generation algorithm of FreeStyle Libre continuous glucose monitoring device

Association of scan frequency with CGM-derived metrics and influential factors in adults with type 1 diabetes mellitus.

The concomitant use of sodium-glucose co-transporter 2 inhibitors improved the renal outcome of Japanese patients with type 2 diabetes treated with glucagon-like peptide 1 receptor agonists.

��ͬ�о�?�������Y��Ȥ��о��n�}

Regulating mechanisms of podocyte differentiation by vitamin D receptor signaling

Development of novel therapies for diabetic nephropathy based on the maintenance of differentiation in podocytes

The study for mechanism of glomerular epithelial cell decrease in human diabetic nephropathy.